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Abstract
Background: Cache Valley virus (CVV) is a mosquito-borne orthobunyavirus endemic in North America. The virus is
an important agricultural pathogen leading to abortion and embryonic lethality in ruminant species, especially
sheep. The importance of CVV in human public health has recently increased because of the report of severe
neurotropic diseases. However, mosquito species responsible for transmission of the virus to humans remain to be
determined. In this study, vector competence of three Culex species mosquitoes of public health importance, Culex
pipiens, Cx. tarsalis and Cx. quinquefasciatus, was determined in order to identify potential bridge vector species
responsible for the transmission of CVV from viremic vertebrate hosts to humans.
Results: Variation of susceptibility to CVV was observed among selected Culex species mosquitoes tested in this
study. Per os infection resulted in the establishment of infection and dissemination in Culex tarsalis, whereas Cx.
pipiens and Cx. quinquefasciatus were highly refractory to CVV. Detection of viral RNA in saliva collected from
infected Cx. tarsalis provided evidence supporting its role as a competent vector.
Conclusions: Our study provided further understanding of the transmission cycles of CVV and identifies Cx. tarsalis
as a competent vector.
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Background
Cache Valley virus (CVV) is an orthobunyavirus endemic
in North America [1–9]. Enzootic transmission of CVV
occurs among ungulates through bites of competent
arthropod vectors. Data from serological surveys and ex-
perimental infections indicate that white-tailed deer
(Odocoileus virginianus) are likely to be the amplification
hosts of the virus in nature [4–6, 8]. Historically, CVV
has been regarded as an important agricultural pathogen
in the USA but not a threat to people. Infection in adult
sheep is common and results in recovery and serocon-
version; however, infection during pregnancy often leads
to embryonic and fetal death, stillbirths and multiple
congenital malformations [10, 11]. The public health sig-
nificance of CVV has been increasingly recognized
because of recent reports of human diseases caused by
infection of CVV and its variants. Four human cases of
CVV infection have been diagnosed in the USA since
1995. In addition to the fatal case reported in North
Carolina, neuroinvasion of CVV has been observed dur-
ing the acute phase of the disease [12–15]. Seropreva-
lence rates among individuals with exposure to farm and
wild animals in the USA were reported to exceed 3%
[16]. A serological survey found that 5–7% of human
serum samples, collected from two cities in Argentina,
were positive for neutralizing antibodies [17]. It is pos-
sible that human infections in the Americas may be
higher than indicated by the low number of symptom-
atic cases.
Whilst entomological surveys have been performed in
the past, the objective of previously published studies
was mainly to identify the species of enzootic vectors
and their roles in the transmission and maintenance of
CVV. It is well-accepted that multiple mosquito species
in North America are competent for the transmission of
CVV [2]. Six mosquito species have been demonstrated
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to be competent for CVV under laboratory conditions:
Culiseta inornata, Anopheles quadrimaculatus, Coquil-
lettidia perturbans, Aedes sollicitans, Ae. taeniorhynchus
and Ae. japonicus [18–20]. In nature, virus isolations
have been made in at least 16 mosquito species [2, 21].
However, very few studies have been performed to iden-
tify the species responsible for the transmission of CVV
from amplification hosts to humans: so-called bridge
vectors. Endemic vector species of CVV do not show
host preference for humans. For example, Cs. inornata,
one of the principle vector species in nature, does not
normally feed on humans [22]. Similarly, populations of
An. quadrimaculatus and Cq. perturbans have been
shown to predominantly feed on non-human mamma-
lian animals as observed with blood meal analyses con-
ducted in several geographic regions [23–30]. Therefore,
the zoonotic transmission of CVV in specific ecological
conditions may involve other mosquito species that
show host preference for both animals and humans as
observed with multiple zoonotic arboviruses.
Although the percentage of CVV isolates obtained
from Culex species mosquitoes is low in relation to the
total number of available isolates, infection of CVV has
been reported in at least three medically important spe-
cies, Cx. tarsalis, Cx. pipiens and Cx. restuans, collected
in the field. These observations warrant further investi-
gation of whether or not Culex species mosquitoes can
act as bridge vectors for the zoonotic transmission of
CVV [2, 21, 31, 32]. The potential importance of North
American Culex species mosquitoes for the transmission
of zoonotic arboviruses to humans has been
well-established for several viruses including St. Louis
encephalitis virus (SLEV), Western equine encephalitis
virus (WEEV), and West Nile virus (WNV) [33–35].
Therefore, determining the vector competence of medic-
ally important Culex species mosquitoes for CVV is
likely to provide information on the vector species re-
sponsible for its transmission from viremic animals to
humans. Vector competence based on orally challenged
mosquitoes identifies species that are able to transmit
CVV in nature and exclude the candidate vector species
that became a source of viral isolation due to recent en-
gorgement. In this study, three species of mosquitoes,
Cx. pipiens, Cx. quinquefasciatus and Cx. tarsalis, were
evaluated for their vector competence for CVV.
Methods
Cells and virus
African green monkey kidney epithelial Vero 76 cells
were maintained in Leibovitz’s L-15 media (Thermo
Fisher Scientific, Waltham, MA, USA) supplemented
with 10% fetal bovine serum, 10% tryptose phosphate
broth, penicillin/streptomycin, and L-glutamine, and
used in this study for propagation of virus stocks and
titration of homogenized tissues as previously described
[36]. The prototype 6V633 strain of CVV was used in all
oral challenge experiments for the determination of vec-
tor competence. It was originally isolated from infected
Cs. inornata in Cache Valley, Utah, in 1956 [37]. Se-
quences of all three genomic segments have been deter-
mined in a previously published study (GenBank
accession numbers: KX100133.1, KX100134.1 and
KX100135.1) [38]. The strain was obtained from the col-
lection in the laboratory of Dr Richard M. Elliot [39].
Stocks of CVV used in the oral infection study were
generated by two passages in Vero 76 cells.
Mosquitoes
Three medically important mosquitoes, Cx. pipiens, Cx.
tarsalis and Cx. quinquefasciatus, were used in the ex-
periments. Colonies of Cx. pipiens and Cx. quinquefas-
ciatus were established from larvae collected in Ewing
Township, New Jersey and Vero Beach, Florida, as previ-
ously described [40]. Per os infections of the two species
were performed with F8 of Cx. pipiens and F12 of Cx.
quinquefasciatus. Cx. tarsalis used in this study origi-
nated from a collection in Kern County, California [41].
The colonies were maintained by 10% sucrose solution
under a 16:8 h light:dark photoregimen at 28 °C. Female
mosquitoes aged 7–10 days-old were deprived of water
and sucrose 24 and 48 h before per os infection, respect-
ively. Viremic blood meals were prepared by mixing
equal volumes of L-15 media that contained CVV at
7.95 log of 50% tissue culture infectious dose (TCID50)/
ml with defibrinated sheep blood. Control mosquitoes
received blood meals containing a 1:1 volume mixture of
L-15 media and defibrinated sheep blood. Mosquitoes
were allowed to orally ingest artificial infectious blood
meals using previously published techniques [40, 42].
Engorged mosquitoes were collected under cold
anesthesia and returned to designated cartons for
characterization of the infection process. At 7 and 14
days post-infection (dpi), mosquitoes were collected and
divided into two groups to characterize susceptibility to
viral infection and dissemination in dissected mosqui-
toes and replication in whole carcasses. Infection status
of each mosquito was determined by the isolation of in-
fectious viruses using the TCID50-based titration method
as previously described [36, 43]. Infection of individual
mosquitoes was demonstrated by the detection of infec-
tious viruses in dissected tissues or whole carcasses. In-
fection rates were calculated using the percentage of
infected mosquitoes among all mosquitoes tested at each
time-point. Disseminated form of infections were identi-
fied by the detection of infectious viruses in the second-
ary tissues of infected mosquitoes including the head,
wings and legs. Dissemination rates were calculated by
dividing the numbers of positive secondary tissues with
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the number of dissected mosquitoes that were infected
with CVV. Growth kinetics of CVV in infected mosqui-
toes was determined based on the titers of CVV in
whole mosquitoes. At 14 dpi, saliva from mosquitoes
was collected to determine the incidence of transmis-
sion. Saliva was collected by inserting each mosquito’s
proboscis into capillary tubes with type B immersion oil
(Cargille Laboratories Inc., Cedar Grove, NJ, USA) for 1
h as previously described [36].
Detection of CVV
Detection of CVV was performed by either the isolation of
infectious viruses or the detection of viral genome. Quan-
tities of infectious viruses in blood meals and homogenized
mosquito tissues were determined with TCID50-based titra-
tion with Vero 76 cells as previously described [43]. Com-
parison of percentages of infection and dissemination was
performed using Fisher’s exact test. The presence of viral
genome in saliva of orally challenged mosquitoes was dem-
onstrated by reverse-transcriptase polymerase chain reac-
tion (RT-PCR). Extraction of viral RNA was performed
with a QIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA,
USA). Viral RNA was reverse-transcribed with Superscript
III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA).
cDNA was amplified with a nested PCR approach based on
previously published primer sets [44]. The outer primer set
was designed to target nucleotide positions between 2220
and 2520 of the G1 gene encoded within the medium (M)
genome segment. Amplicons derived from the outer primer
set were amplified by the inner primer set targeting the nu-
cleotide positions between 2246 and 2348 of the G1 gene.
Results
Infection and dissemination of CVV
Three species of medically important Culex species mos-
quitoes showed variations in susceptibility to CVV infec-
tion through oral exposure. As summarized in Table 1,
the establishment of infection was only observed in Cx.
tarsalis, whereas two species under the Cx. pipiens com-
plex, Cx. pipiens and Cx. quinquefasciatus, were refrac-
tory to CVV. Infectious viruses of CVV were not
detected among 28 and 27 Cx. pipiens collected at 7 and
14 dpi, respectively. Similarly, Cx. quinquefasciatus
mosquitoes collected at 7 (n = 14) and 14 (n = 18) dpi
did not show a detectable level of infectious viruses.
As demonstrated by the isolation of infectious viruses
in homogenized mosquito tissues, there was no distin-
guishable difference in the infection rates of CVV in Cx.
tarsalis at 7 (81.8%, 18/22) and 14 (82.6%, 19/23) dpi (P
= 1.00). The dissemination rate of CVV in infected Cx.
tarsalis showed a significant increase from 72.7% (8/11)
at 7 dpi to 100.0% (9/9) at 14 dpi (Fisher’s exact test: P <
0.05), presumably due to the continuous viral replication
in permissive tissue. However, there was no demon-
strable difference in the average titer of infected whole
mosquitoes at 7 (5.41 ± 2.06 logTCID50/ml, n = 7) and
14 (5.47 ± 1.07 logTCID50/ml, n = 10) dpi as shown in
Fig. 1. Similarly, there were no significant differences in
the infectious titers of CVV present in the dissected ab-
domen section (7 dpi: 4.23 ± 1.49 logTCID50/ml, n = 11;
14 dpi: 4.91 ± 0.51 logTCID50/ml, n = 8) and secondary
tissues (7 dpi: 5.03±1.48 logTCID50/ml, n = 8; 14 dpi:
5.09 ± 1.48 logTCID50/ml, n = 9).
Detection of infectious viruses in mosquitoes collected
at 7 and 14 dpi indicated that Cx. tarsalis is highly sus-
ceptible to CVV through oral challenge and subse-
quently supports viral replication. Cx. pipiens and Cx.
quinquefasciatus are highly refractory to CVV.
Detection of viral RNA in mosquito saliva
With the high infection and dissemination rates ob-
served in Cx. tarsalis orally challenged with CVV, saliva
obtained through forced salivation of individual mosqui-
toes at 14 dpi was assayed for the presence of the M seg-
ment of viral genome through nested RT-PCR. As
anticipated, none of the saliva samples collected from
Cx. pipiens (n = 27) and Cx. quinquefasciatus (n = 18)
showed a detectable level of viral genome. Viral RNA of
CVV was detected from 31.6% (6/19) of infected Cx. tar-
salis. These results demonstrate that CVV is able to de-
velop disseminated infection in Cx. tarsalis, which can
subsequently be competent for its transmission.
Discussion
The confirmation of Cx. tarsalis as a competent vector
is of high public and veterinary health importance.
Table 1 Summary of infection and dissemination rates in Culex species mosquitoes orally challenged with Cache Valley virus
Mosquito species 7 dpi 14 dpi
Infection rate (%)a Dissemination rate (%)b Infection rate (%)a Dissemination rate (%)b
Cx. tarsalis 81.8 (18/22) 72.7 (8/11) 82.6 (19/23) 100.0 (9/9)
Cx. pipiens 0.0 (0/28) na 0.0 (0/27) na
Cx. quinquefasciatus 0.0 (0/14) na 0.0 (0/18) na
Abbreviation: na not available
aInfection rates were derived from the percentage of infected mosquitoes among all the mosquitoes tested at each time-point (numbers in parentheses)
bDissemination rates were calculated by dividing the numbers of mosquitoes containing positive secondary tissues with the number of dissected mosquitoes that
were infected by CVV (numbers in parentheses)
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Previous analyses of the blood-feeding behavior of Cx.
tarsalis further supports its potential role in maintaining
enzootic transmission of CVV, especially in the Mid-
western states of the USA. In two independent studies,
Cx. tarsalis from North Dakota and Minnesota, where
CVV is endemic, showed relatively high frequencies of
feeding on white-tailed deer, a known amplification host
of CVV in nature [4, 45, 46]. In addition to its role as an
enzootic vector, the established role of Cx. tarsalis as a
vector species for SLEV, WNV and WEEV in western
USA and its documented feeding on humans further
supports the hypothesis that it may be involved in trans-
mission of CVV from viremic animals to humans [34,
35]. Although there is variation in the frequency of feed-
ing on humans, engorgement from human blood has
been repeatedly observed in multiple populations of Cx.
tarsalis in nature [29, 45–47]. Host preference is, in part,
determined by changes in host availability, suggesting
that the contact rate with humans may depend on the
diversity of other potential hosts [48, 49].
As a species that has evolved to hibernate and has
been shown to support the overwintering of arboviruses
such as SLEV, WNV and WEEV [50, 51], our findings
also highlight the need to further investigate the ecology
of Cx. tarsalis and its involvement in the overwintering
maintenance of CVV in nature. Similar to other ortho-
bunyaviruses, vertical transmission has been demon-
strated to be a likely overwintering mechanism for CVV
[52]. For instance, 2.9 to 3.3% of experimentally infected
Cs. inornata transovarially transmitted CVV to both
male and female progeny. Further investigations in the
detection of CVV in overwintering populations of Cx.
tarsalis in nature will provide much needed understand-
ing of the maintenance of CVV.
Whilst the number of reported neurotropic cases of
CVV remains low, the advancement of virological and
molecular biological techniques has led to the identifica-
tion of variants or subtypes of CVV that are responsible
for human diseases throughout the New World [53]. In
1985, the isolation of Fort Sherman virus was made from
an American soldier in Panama who developed fever
and an erythematous pharynx at the acute phase of in-
fection [54]. Similarly, Maguari virus, another orthobu-
nyavirus closely related to CVV, has been continuously
found in multiple Latin American countries causing fe-
brile illness in humans [38]. It remains unclear if other
pathogenic orthobunyaviruses closely related to CVV
can also utilize Cx. tarsalis or other medically important
Culex species mosquitoes for transmission or mainten-
ance. As observed with many other pathogenic arbovi-
ruses, identification of competent vector species can be
an important step in formulating control strategies in
the event of emergence.
Conclusions
Since the original isolation of CVV in 1956, there have
been isolates and detections of CVV made in Culex spe-
cies mosquitoes [2, 21]. It has been unclear if the isola-
tion or detection of CVV in Culex species mosquitoes
was caused by recent engorgement of blood from
viremic vertebrate hosts, which can cause a transient
presence of infectious viruses and viral genomes in mos-
quitoes or actual viral replication, which is likely to re-
sult in a disseminated form of infection and
transmission. To the best of our knowledge, this study
provides the first direct evidence that Cx. tarsalis is sus-
ceptible to oral infection of CVV and competent for its
transmission. Although we cannot exclude the possibility
that other members in the Cx. pipiens complex can be
competent for the transmission of CVV, the results of
this study demonstrate that Cx. pipiens in New Jersey
and Cx. quinquefasciatus in Florida, are highly refractory
to CVV and are less likely to serve as competent vectors
to support its transmission in nature.
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